ATE480227T1 - Pharmazeutische zusammensetzungen mit quetiapinfumarat - Google Patents

Pharmazeutische zusammensetzungen mit quetiapinfumarat

Info

Publication number
ATE480227T1
ATE480227T1 AT07380037T AT07380037T ATE480227T1 AT E480227 T1 ATE480227 T1 AT E480227T1 AT 07380037 T AT07380037 T AT 07380037T AT 07380037 T AT07380037 T AT 07380037T AT E480227 T1 ATE480227 T1 AT E480227T1
Authority
AT
Austria
Prior art keywords
quetiapinfumarate
pharmaceutical compositions
compositions containing
pharmaceutical
containing quetiapinfumarate
Prior art date
Application number
AT07380037T
Other languages
English (en)
Inventor
Amenos Anna Ruiz
Perez Carmen Ubeda
Martin Ignacio Diez
Original Assignee
Lesvi Laboratorios Sl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38089224&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE480227(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lesvi Laboratorios Sl filed Critical Lesvi Laboratorios Sl
Application granted granted Critical
Publication of ATE480227T1 publication Critical patent/ATE480227T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5015—Organic compounds, e.g. fats, sugars
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/554—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one sulfur as ring hetero atoms, e.g. clothiapine, diltiazem
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
AT07380037T 2007-02-14 2007-02-14 Pharmazeutische zusammensetzungen mit quetiapinfumarat ATE480227T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP07380037A EP1958617B1 (de) 2007-02-14 2007-02-14 Pharmazeutische Zusammensetzungen mit Quetiapinfumarat

Publications (1)

Publication Number Publication Date
ATE480227T1 true ATE480227T1 (de) 2010-09-15

Family

ID=38089224

Family Applications (1)

Application Number Title Priority Date Filing Date
AT07380037T ATE480227T1 (de) 2007-02-14 2007-02-14 Pharmazeutische zusammensetzungen mit quetiapinfumarat

Country Status (9)

Country Link
US (1) US20080193527A1 (de)
EP (1) EP1958617B1 (de)
AR (1) AR065342A1 (de)
AT (1) ATE480227T1 (de)
CL (1) CL2008000454A1 (de)
DE (1) DE602007009036D1 (de)
ES (2) ES2352299T3 (de)
PT (1) PT1958617E (de)
WO (1) WO2008098969A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20022394A1 (it) 2002-11-13 2004-05-14 Bracco Spa Uso di triiodotironina 3-solfato come farmaco ad attivita' tireomimetica e relative formulazioni farmaceutiche.
ITMI20110713A1 (it) 2011-04-29 2012-10-30 Bracco Imaging Spa Processo per la preparazione di un derivato solfatato di3,5-diiodo-o-[3-iodofenil]-l-tirosina
WO2011154118A1 (en) * 2010-06-07 2011-12-15 Alfred E. Tiefenbacher (Gmbh & Co. Kg) Quetiapine prolonged-release tablets
TR201104977A1 (tr) * 2011-05-23 2012-12-21 Sanovel İlaç Sanayi̇ Ve Ti̇caret Anoni̇m Şi̇rketi̇ Kontrollü salım gerçekleştiren kaplamaya sahip ketiapin formülasyonu.
DE102011115690A1 (de) 2011-10-11 2013-04-11 Acino Pharma Ag Quetiapin enthaltende Formulierungen
WO2013100879A1 (en) * 2011-12-27 2013-07-04 Mahmut Bilgic Pharmaceutical compositions comprising quetiapine
EP2848244A1 (de) 2013-09-16 2015-03-18 Yildiz Özsoy Erginer Tablettenformulierungen mit verzögerter Freisetzung aus Quetiapin
CN104523600A (zh) * 2014-11-21 2015-04-22 哈尔滨圣吉药业股份有限公司 一种富马酸喹硫平缓释微丸及其制备方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4820627A (en) * 1986-03-24 1989-04-11 Em Diagnostic Systems, Inc. Method of preparing particles suitable for tabletting into diagnostic reagents
US5948437A (en) * 1996-05-23 1999-09-07 Zeneca Limited Pharmaceutical compositions using thiazepine
GB9611328D0 (en) 1996-05-31 1996-08-07 Zeneca Ltd Pharmaceutical compositions
GB9716161D0 (en) 1997-08-01 1997-10-08 Zeneca Ltd Process
US5843477A (en) * 1997-09-30 1998-12-01 Bayer Corporation Lubricants for use in tabletting
US6248363B1 (en) * 1999-11-23 2001-06-19 Lipocine, Inc. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
GB9922271D0 (en) * 1999-09-21 1999-11-17 Zeneca Ltd Formulation
US20050003001A1 (en) 2001-11-07 2005-01-06 Hisami Yamaguchi Method for improving dissolution of poorly dispersible medicaments
EP2000141A1 (de) 2002-03-20 2008-12-10 Teva Pharmaceutical Industries Ltd. Verfahren zur Herstellung von Kristalline Quetiapinhemifumarat
US7238686B2 (en) 2003-03-03 2007-07-03 Hetero Drugs Limited Polymorphs of quetiapine fumarate
ES2223294B2 (es) 2003-08-08 2005-10-01 Vita Cientifica, S.L. Procedimiento de preparacion de un compuesto farmaceuticamente activo.
WO2005041935A1 (en) * 2003-10-21 2005-05-12 Alpharma, Inc. Pharmaceutical formulations containing quetiapine
US20060280795A1 (en) * 2005-06-08 2006-12-14 Dexcel Pharma Technologies, Ltd. Specific time-delayed burst profile delivery system
US20070207116A1 (en) * 2006-03-01 2007-09-06 Brown David C Antioxidant compositions for the eye

Also Published As

Publication number Publication date
EP1958617B1 (de) 2010-09-08
CL2008000454A1 (es) 2008-05-23
DE602007009036D1 (de) 2010-10-21
AR065342A1 (es) 2009-06-03
ES2315159B1 (es) 2009-12-22
ES2315159A1 (es) 2009-03-16
US20080193527A1 (en) 2008-08-14
WO2008098969A1 (en) 2008-08-21
EP1958617A1 (de) 2008-08-20
ES2352299T3 (es) 2011-02-17
PT1958617E (pt) 2010-10-28

Similar Documents

Publication Publication Date Title
LTC2140867I2 (lt) Farmacinė kompozicija
LTPA2018014I1 (lt) Farmacinė kompozicija 514
ATE493119T1 (de) Pharmazeutische zusammensetzung
BRPI0721651A2 (pt) Composição farmacêutica
BRPI0715712A2 (pt) Composição farmacêutica
BRPI0820381A2 (pt) Formulações farmacêuticas
DK3492069T3 (da) Farmaceutiske sammensætninger omfattende jern-oxy-hydroxid
ATE489078T1 (de) Pharmazeutische zusammensetzungen mit rosuvastatin-calcium
BRPI0810928A2 (pt) "composição farmacêutica"
BRPI0719393A2 (pt) Composição farmacêutica
DK2073795T3 (da) Misbrugssikret lægemiddelformulation
DK2041139T3 (da) Farmaceutiske forbindelser
ATE517619T1 (de) Stabilisierte pharmazeutische zusammensetzung mit fesoterodin
DK2343071T3 (da) Farmaceutiske doseringsformer
BRPI0716445A2 (pt) composiÇço farmacÊutica
BRPI0720234A2 (pt) Composição farmacêutica
DK2285413T3 (da) Farmaceutisk sammensætning
BRPI0817833A2 (pt) Composição farmacêutica antimalárica
DK2966175T3 (da) Farmaceutiske sammensætninger indeholdende cortexolon-17-alpha-propionat
BRPI0921313A2 (pt) composição farmaucêutica
BRPI0820198A2 (pt) composições farmacêuticas
ATE480227T1 (de) Pharmazeutische zusammensetzungen mit quetiapinfumarat
DE602008005137D1 (de) Chinolonverbindung und pharmazeutische zusammensetzung
BRPI0912171A2 (pt) composição farmacêutica
DK2271321T3 (da) Farmaceutisk sammensætning 271

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties